Skip to main content
. Author manuscript; available in PMC: 2019 Sep 4.
Published in final edited form as: Circulation. 2018 Sep 4;138(10):1039–1053. doi: 10.1161/CIRCULATIONAHA.118.034668

Figure 3.

Figure 3.

Influence of aliskiren on longitudinal NT-proBNP level in the ASTRONAUT trial by atrial fibrillation/flutter status. The y-axis represents the estimated NT-proBNP level in pg/mL, derived from exponentiation of the log-transformed NT-proBNP level at each time point. NTproBNP, N-terminal pro-B-type natriuretic peptide. Adapted with permission from Greene SJ et al.30